Interestingly, Fezf2 suppresses the expression of some self-antigens among which are some TAAs such as Mesothelin (Msln), which is known to be overexpressed in several human cancers, implying the possibility of the existence of a regulatory mechanism that allows the generation of an antitumor immune defense [63, 64]. This evidence concerns the gene MSLN and cancer.